ArticleActa neurochirurgica2025
The NeVa Net stent-retriever - initial report of 20 cases from two high volume centres.
Article in Acta neurochirurgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Stent retrievers for acute ischemic stroke: technological advances, clinical applications, and future perspectives.Journal of neurology · 2026Review
- Case Report: Mechanical thrombectomy of cerebral venous sinuses using the NeVa stent retriever.Frontiers in radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVarious different technologies have been developed to optimise the mechanical thrombectomy procedure and first pass recanalisation. We report our initial experience with the NeVa NET - a novel stent-retriever with built in distal microfiltration net. MATERIALS AND
methodsWe performed a retrospective review of our prospectively maintained databases to identify all patients treated with the NeVa NET 4 × 30 mm device. We recorded the baseline demographics, NIHSS, ASPECT score and clot characteristics, first pass and final eTICI scores, complications and 90 day mRS.
resultsWe identified 20 patients (50% male), average age 67.9 ± 16.2 yrs, and median NIHSS 18 (range 6-29). 30% of patients received tPA. Average clot length was 21.6 ± 8.9 mm and median ASPECT score 9 (range 5-10). In 18 cases the NeVa NET could be tracked into position, however, in 2 cases it could not be tracked into position within the 0,021inch microcatheter. First pass recanalization (eTICI ≥ 2c) was seen in 94% (n = 17) and the average number of NeVa NET passes was 1. A final eTICI score of ≥ 2c was achieved in 17 patients (94%). There were no emboli to new territories. No cases of vessel rupture or dissections occured due to the NeVa NET. 50% of patients achieved mRS 0-2. SAH was seen in 31.3% and SICH in 6.3% of the 16 patients for whom a 24 h CT head was available.
conclusionThe NeVa Net stent-retriever is uniquely designed to prevent distal embolisation and our initial experience demonstrates a very high FPE and mFPE. We believe this is the first publication on the use of this novel technology and larger studies are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.